At the KDA November Board meeting.The KDA Board met with the KDA Scientific Review Board during the KDA Conference in Orlando, Florida.
The aim of this study was to determine the frequency and relative importance of symptoms experienced by patients with spinal and bulbar muscular atrophy (SBMA).
A 2023 research article from researchers in Italy contains a graphic about the various therapies (like AJ201) that are or have been tried to deal with the toxic Androgen Receptor in Kennedy's Disease.
